ロード中...
Tolvaptan and Kidney Pain in Patients With Autosomal Dominant Polycystic Kidney Disease: Secondary Analysis From a Randomized Controlled Trial
BACKGROUND: Kidney pain is a common complication in patients with autosomal dominant polycystic kidney disease (ADPKD), and data from the TEMPO 3:4 trial suggested that tolvaptan, a vasopressin V2 receptor antagonist, may have a positive effect on kidney pain in this patient group. Because pain is d...
保存先:
| 出版年: | Am J Kidney Dis |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5497700/ https://ncbi.nlm.nih.gov/pubmed/27856088 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.ajkd.2016.08.028 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|